Home NDC 51079-345 Risperidone
Product NDC 51079-345
11-digit product format 510790345
Labeler code 51079
Product ID 51079-345_7d8ee118-5731-08c9-e053-2a91aa0ae10f
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name risperidone
Dosage form TABLET, ORALLY DISINTEGRATING
Route ORAL
Labeler Mylan Institutional Inc.
Application ANDA091537
Marketing category ANDA
Marketing start 2011-06-10
Marketing end 0000-00-00
Substance RISPERIDONE
Active strength 1 mg/1
Pharmacologic classes Atypical Antipsychotic [EPC]
NDC exclude flag No
Listing certified through 2019-12-31
Current FDA listing Historical FDA.report record
Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 24 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 51079-345-05 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 51079-345-05 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 51079-345-05 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 51079-345-05 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 51079-345-05 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 51079-345-05 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 51079-345-05 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 51079-345-05 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 51079-345-05 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 excluded product product ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 51079-345-05 ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 excluded product product 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 51079-345-05 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded product product 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 51079-345-05 557ba5c1ecfa…9c80585c8c6e…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 45 .
Orange Book products# Current product rows page 1 of 1 · 6 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A091537-001 RISPERIDONE RISPERIDONE 0.5MG TABLET, ORALLY DISINTEGRATING / ORAL 2011-03-30 A091537-002 RISPERIDONE RISPERIDONE 1MG TABLET, ORALLY DISINTEGRATING / ORAL 2011-03-30 A091537-003 RISPERIDONE RISPERIDONE 2MG TABLET, ORALLY DISINTEGRATING / ORAL 2011-03-30 A091537-004 RISPERIDONE RISPERIDONE 3MG TABLET, ORALLY DISINTEGRATING / ORAL 2011-03-30 A091537-005 RISPERIDONE RISPERIDONE 4MG TABLET, ORALLY DISINTEGRATING / ORAL 2011-03-30 A091537-006 RISPERIDONE RISPERIDONE 0.25MG TABLET, ORALLY DISINTEGRATING / ORAL 2013-02-12
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 7 · 270 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-11-14 07:37:17 2026-10 A091537-001 RISPERIDONE 0.5MG TABLET, ORALLY DISINTEGRATING / ORAL 2011-03-30 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 A091537-002 RISPERIDONE 1MG TABLET, ORALLY DISINTEGRATING / ORAL 2011-03-30 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 A091537-003 RISPERIDONE 2MG TABLET, ORALLY DISINTEGRATING / ORAL 2011-03-30 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 A091537-004 RISPERIDONE 3MG TABLET, ORALLY DISINTEGRATING / ORAL 2011-03-30 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 A091537-005 RISPERIDONE 4MG TABLET, ORALLY DISINTEGRATING / ORAL 2011-03-30 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 A091537-006 RISPERIDONE 0.25MG TABLET, ORALLY DISINTEGRATING / ORAL 2013-02-12 d4dbc9d85df4…2026-10-15 13:18:30 2026-09 A091537-001 RISPERIDONE 0.5MG TABLET, ORALLY DISINTEGRATING / ORAL 2011-03-30 c2088c7a36db…2026-10-15 13:18:30 2026-09 A091537-002 RISPERIDONE 1MG TABLET, ORALLY DISINTEGRATING / ORAL 2011-03-30 c2088c7a36db…2026-10-15 13:18:30 2026-09 A091537-003 RISPERIDONE 2MG TABLET, ORALLY DISINTEGRATING / ORAL 2011-03-30 c2088c7a36db…2026-10-15 13:18:30 2026-09 A091537-004 RISPERIDONE 3MG TABLET, ORALLY DISINTEGRATING / ORAL 2011-03-30 c2088c7a36db…2026-10-15 13:18:30 2026-09 A091537-005 RISPERIDONE 4MG TABLET, ORALLY DISINTEGRATING / ORAL 2011-03-30 c2088c7a36db…2026-10-15 13:18:30 2026-09 A091537-006 RISPERIDONE 0.25MG TABLET, ORALLY DISINTEGRATING / ORAL 2013-02-12 c2088c7a36db…2026-09-14 22:38:34 2026-08 A091537-001 RISPERIDONE 0.5MG TABLET, ORALLY DISINTEGRATING / ORAL 2011-03-30 84e616aacf4f…2026-09-14 22:38:34 2026-08 A091537-002 RISPERIDONE 1MG TABLET, ORALLY DISINTEGRATING / ORAL 2011-03-30 84e616aacf4f…2026-09-14 22:38:34 2026-08 A091537-003 RISPERIDONE 2MG TABLET, ORALLY DISINTEGRATING / ORAL 2011-03-30 84e616aacf4f…2026-09-14 22:38:34 2026-08 A091537-004 RISPERIDONE 3MG TABLET, ORALLY DISINTEGRATING / ORAL 2011-03-30 84e616aacf4f…2026-09-14 22:38:34 2026-08 A091537-005 RISPERIDONE 4MG TABLET, ORALLY DISINTEGRATING / ORAL 2011-03-30 84e616aacf4f…2026-09-14 22:38:34 2026-08 A091537-006 RISPERIDONE 0.25MG TABLET, ORALLY DISINTEGRATING / ORAL 2013-02-12 84e616aacf4f…2026-08-18 06:07:40 2026-07 A091537-001 RISPERIDONE 0.5MG TABLET, ORALLY DISINTEGRATING / ORAL 2011-03-30 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A091537-002 RISPERIDONE 1MG TABLET, ORALLY DISINTEGRATING / ORAL 2011-03-30 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A091537-003 RISPERIDONE 2MG TABLET, ORALLY DISINTEGRATING / ORAL 2011-03-30 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A091537-004 RISPERIDONE 3MG TABLET, ORALLY DISINTEGRATING / ORAL 2011-03-30 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A091537-005 RISPERIDONE 4MG TABLET, ORALLY DISINTEGRATING / ORAL 2011-03-30 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A091537-006 RISPERIDONE 0.25MG TABLET, ORALLY DISINTEGRATING / ORAL 2013-02-12 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A091537-001 RISPERIDONE 0.5MG TABLET, ORALLY DISINTEGRATING / ORAL 2011-03-30 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A091537-002 RISPERIDONE 1MG TABLET, ORALLY DISINTEGRATING / ORAL 2011-03-30 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A091537-003 RISPERIDONE 2MG TABLET, ORALLY DISINTEGRATING / ORAL 2011-03-30 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A091537-004 RISPERIDONE 3MG TABLET, ORALLY DISINTEGRATING / ORAL 2011-03-30 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A091537-005 RISPERIDONE 4MG TABLET, ORALLY DISINTEGRATING / ORAL 2011-03-30 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A091537-006 RISPERIDONE 0.25MG TABLET, ORALLY DISINTEGRATING / ORAL 2013-02-12 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A091537-001 RISPERIDONE 0.5MG TABLET, ORALLY DISINTEGRATING / ORAL 2011-03-30 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A091537-002 RISPERIDONE 1MG TABLET, ORALLY DISINTEGRATING / ORAL 2011-03-30 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A091537-003 RISPERIDONE 2MG TABLET, ORALLY DISINTEGRATING / ORAL 2011-03-30 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A091537-004 RISPERIDONE 3MG TABLET, ORALLY DISINTEGRATING / ORAL 2011-03-30 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A091537-005 RISPERIDONE 4MG TABLET, ORALLY DISINTEGRATING / ORAL 2011-03-30 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A091537-006 RISPERIDONE 0.25MG TABLET, ORALLY DISINTEGRATING / ORAL 2013-02-12 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A091537-001 RISPERIDONE 0.5MG TABLET, ORALLY DISINTEGRATING / ORAL 2011-03-30 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A091537-002 RISPERIDONE 1MG TABLET, ORALLY DISINTEGRATING / ORAL 2011-03-30 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A091537-003 RISPERIDONE 2MG TABLET, ORALLY DISINTEGRATING / ORAL 2011-03-30 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A091537-004 RISPERIDONE 3MG TABLET, ORALLY DISINTEGRATING / ORAL 2011-03-30 6a471c1ec25d…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded RISPERIDONE ACTIVE INGREDIENT L6UH7ZF8HC RISPERIDONE TABLET, ORALLY DISINTEGRATING [MYLAN INSTITUTIONAL INC.] 3 RISPERIDONE ACTIVE MOIETY L6UH7ZF8HC RISPERIDONE TABLET, ORALLY DISINTEGRATING [MYLAN INSTITUTIONAL INC.] 3 ASPARTAME INACTIVE INGREDIENT Z0H242BBR1 RISPERIDONE TABLET, ORALLY DISINTEGRATING [MYLAN INSTITUTIONAL INC.] 3 CROSPOVIDONE INACTIVE INGREDIENT 68401960MK RISPERIDONE TABLET, ORALLY DISINTEGRATING [MYLAN INSTITUTIONAL INC.] 3 DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER INACTIVE INGREDIENT 905HNO1SIH RISPERIDONE TABLET, ORALLY DISINTEGRATING [MYLAN INSTITUTIONAL INC.] 3 FD&C BLUE NO. 1 INACTIVE INGREDIENT H3R47K3TBD RISPERIDONE TABLET, ORALLY DISINTEGRATING [MYLAN INSTITUTIONAL INC.] 3 FD&C YELLOW NO. 6 INACTIVE INGREDIENT H77VEI93A8 RISPERIDONE TABLET, ORALLY DISINTEGRATING [MYLAN INSTITUTIONAL INC.] 3 LACTOSE MONOHYDRATE INACTIVE INGREDIENT EWQ57Q8I5X RISPERIDONE TABLET, ORALLY DISINTEGRATING [MYLAN INSTITUTIONAL INC.] 3 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 RISPERIDONE TABLET, ORALLY DISINTEGRATING [MYLAN INSTITUTIONAL INC.] 3 MANNITOL INACTIVE INGREDIENT 3OWL53L36A RISPERIDONE TABLET, ORALLY DISINTEGRATING [MYLAN INSTITUTIONAL INC.] 3 SILICON DIOXIDE INACTIVE INGREDIENT ETJ7Z6XBU4 RISPERIDONE TABLET, ORALLY DISINTEGRATING [MYLAN INSTITUTIONAL INC.] 3 SODIUM LAURYL SULFATE INACTIVE INGREDIENT 368GB5141J RISPERIDONE TABLET, ORALLY DISINTEGRATING [MYLAN INSTITUTIONAL INC.] 3 SODIUM STEARYL FUMARATE INACTIVE INGREDIENT 7CV7WJK4UI RISPERIDONE TABLET, ORALLY DISINTEGRATING [MYLAN INSTITUTIONAL INC.] 3 SORBITOL INACTIVE INGREDIENT 506T60A25R RISPERIDONE TABLET, ORALLY DISINTEGRATING [MYLAN INSTITUTIONAL INC.] 3 STEARIC ACID INACTIVE INGREDIENT 4ELV7Z65AP RISPERIDONE TABLET, ORALLY DISINTEGRATING [MYLAN INSTITUTIONAL INC.] 3